| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| United States Patent and Trademark Office (USPTO) |
| Patent ID |
US9182402 |
| Title |
Hepsin inhibitors |
| Abstract |
Compositions and methods are provided for preventing or attenuating cancer progression or blocking metastasis in prostate cancer and other cancers (e.g., ovarian carcinoma, endometrial cancer, renal cell carcinoma) that are characterized by overexpression of the type II cell surface serine protease hepsin, based on the discovery of multiple disclosed compounds having activity as specific hepsin inhibitors. |
| Applicant(s) |
Fred Hutchinson Cancer Research Center |
| Patent ID |
US9182402 |
| Title |
Hepsin inhibitors |
| Abstract |
Compositions and methods are provided for preventing or attenuating cancer progression or blocking metastasis in prostate cancer and other cancers (e.g., ovarian carcinoma, endometrial cancer, renal cell carcinoma) that are characterized by overexpression of the type II cell surface serine protease hepsin, based on the discovery of multiple disclosed compounds having activity as specific hepsin inhibitors. |
| Applicant(s) |
Fred Hutchinson Cancer Research Center |
| Patent ID |
US9182402 |
| Title |
Hepsin inhibitors |
| Abstract |
Compositions and methods are provided for preventing or attenuating cancer progression or blocking metastasis in prostate cancer and other cancers (e.g., ovarian carcinoma, endometrial cancer, renal cell carcinoma) that are characterized by overexpression of the type II cell surface serine protease hepsin, based on the discovery of multiple disclosed compounds having activity as specific hepsin inhibitors. |
| Applicant(s) |
Fred Hutchinson Cancer Research Center |
